37/15. Daratumumab- (DARZALEX)- (Nov 2015)- to treat patients with multiple myeloma who have received at least three prior treatments
Drug Name:37/15. Daratumumab- (DARZALEX)- (Nov 2015)- to treat patients with multiple myeloma who have received at least three prior treatments
List Of Brands:
Indication Type Description:
